1
|
Al-Jafari AA and Cryer A: The lipoprotein
lipase of white adipose tissue. Studies on the intracellular
distribution of the adipocyte-associated enzyme. Biochem J.
236:749–756. 1986.PubMed/NCBI
|
2
|
Auwerz J, Leroy P and Schoonjans K:
Lipoprotein lipase: recent contributions from molecular biology.
Crit Rev Clin Lab Sci. 29:243–268. 1992. View Article : Google Scholar : PubMed/NCBI
|
3
|
Saxena U, Klein MG, Vanni TM and Goldberg
IJ: Lipoprotein lipase increases low density lipoprotein retention
by subendothelial cell matrix. J Clin Invest. 89:373–380. 1992.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Goldbourt U, Yaari S and Medalie JH:
Isolated low HDL cholesterol as a risk factor for coronary heart
disease mortality. A 21-year follow-up of 8000 men. Arterioscler
Thromb Vasc Biol. 17:107–113. 1997.PubMed/NCBI
|
5
|
Stephens JW and Humphries SE: The
molecular genetics of cardiovascular disease: clinical
implications. J Intern Med. 253:120–127. 2003. View Article : Google Scholar : PubMed/NCBI
|
6
|
Su Z, Zhang S, Hou Y, Zhang Li, Liao L and
Xiao C: Relationship between a novel polymorphism of lipoprotein
lipase gene and coronary heart disease. Chin Med J (Engl).
115:677–680. 2002.PubMed/NCBI
|
7
|
Anderson JL, King GJ, Bair TL, Elmer SP,
Muhlestein JB, Habashi J, Mixson L and Carlquist JF: Association of
lipoprotein lipase gene polymorphism with coronary artery disease.
J Am Coll Cardiol. 33:1013–1020. 1999. View Article : Google Scholar : PubMed/NCBI
|
8
|
Sagoo GS, Tatt I, Salanti G, Butterworth
AS, Sarwar N, van Maarle M, Jukema JW, Wiman B, Kastelein JJ,
Bennet AM, et al: Seven lipoprotein gene polymorphisms, lipid
fractions, and coronary disease: A HuGE association review and
meta-analysis. Am J Epidemiol. 168:1233–1246. 2008. View Article : Google Scholar : PubMed/NCBI
|
9
|
Emi M, Wilson DE, Iverius PH, Wu L, Hata
A, Hegele R, Williams RR and Lalouel JM: Missense mutations (Gly -
Glu 188) of human lipoprotein lipase imparting functional
deficiency. J Biol Chem. 10:5910–5916. 1990.PubMed/NCBI
|
10
|
Hallman DM, Groenemeijer BE, Jukema JW,
Boerwinkle E and Kastelein JJ: Analysis of lipoprotein lipase
haplotypes reveals associations not apparent from analysis of the
constituent loci. Ann Hum Genet. 63:499–510. 1999. View Article : Google Scholar : PubMed/NCBI
|
11
|
Hu Y, Liu W, Huang R and Zhang X: A
systematic review and meta-analysis of the relationship between
lipoprotein lipase Asn291Ser variant and diseases. J Lipid Res.
47:1908–1914. 2006. View Article : Google Scholar : PubMed/NCBI
|
12
|
Wittrup HH, Tybjaerg-Hansen A and
Nordestgaard BG: Lipoprotein lipase mutations, plasma lipids and
lipoproteins, and risk of ischemic heart disease. A meta-analysis.
Circulation. 99:2901–2907. 1999. View Article : Google Scholar : PubMed/NCBI
|
13
|
Socquard E, Durlach A, Clavel C,
Nazeyrollas P and Durlach V: Association of HindIII and PvuII
genetic polymorphisms of lipo-protein lipase with lipid metabolism
and macrovascular events in type 2 diabetic patients. Diabetes
Metab. 32:262–269. 2006. View Article : Google Scholar : PubMed/NCBI
|
14
|
Gigek Cde O, Chen ES, Cendoroglo MS, Ramos
LR, Araujo LM, Payao SL and Smith Mde A: Association of lipoprotein
lipase polymorphisms with myocardial infarction and lipid levels.
Clin Chem Lab Med. 45:599–604. 2007.PubMed/NCBI
|
15
|
McGladdery SH, Pimstone SN, Clee SM,
Bowden JF, Hayden MR and Frohlich JJ: Common mutations in the
lipoprotein lipase gene (LPL): effects on HDL-cholesterol levels in
a Chinese Canadian population. Atherosclerosis. 156:401–407. 2001.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Brousseau ME, Goldkamp AL, Collins D,
Demissie S, Connolly AC, Cupples LA, Ordovas JM, Bloomfield HE,
Robins SJ and Schaefer EJ: Polymorphisms in the gene encoding
lipoprotein lipase in men with low HDL-C and coronary heart
disease: the Veterans Affairs. HDL Intervention. Trial J Lipid Res.
45:1885–1891. 2004. View Article : Google Scholar : PubMed/NCBI
|
17
|
Ferencak G, Pasalic D, Grskovic B, Cheng
S, Fijal B, Sesto M, Skodlar J and Rukavina AS: Lipoprotein lipase
gene polymorphisms in Croatian patients with coronary artery
disease. Clin Chem Lab Med. 41:541–546. 2003. View Article : Google Scholar : PubMed/NCBI
|
18
|
Sawano M, Watanabe Y, Ohmura H, Shimada K,
Diada H, Mokuno H and Yamaguchi H: Potentailly protective effects
of the Ser447-Ter mutation of the lipoprotein lipase gene against
the development of coronary artery disease in Japanese subjects via
a beneficial lipid profile. Jpn Circ J. 65:310–314. 2001.
View Article : Google Scholar
|
19
|
Shimo-Nakanishi Y, Urabe T, Hattori N,
Watanabe Y, Nagao T, Yokochi M, Hamamoto M and Mizuno Y:
Polymorphism of the lipoprotein lipase gene and risk of
atherothrombotic cerebral infarction in the Japanese. Stroke.
32:1481–1486. 2001. View Article : Google Scholar : PubMed/NCBI
|
20
|
Fisher RM, Humphries SE and Talmud PJ:
Common variation in the lipoprotein lipase gene: effects on plasma
lipids and risk of atherosclerosis. Atherosclerosis. 135:145–159.
1997. View Article : Google Scholar : PubMed/NCBI
|
21
|
Murthy V, Julien P and Gagne C: Molecular
pathobiology of the human lipoprotein lipase gene. Pharmacol Ther.
70:101–135. 1996. View Article : Google Scholar : PubMed/NCBI
|
22
|
Gensini GF, Comeglio M and Colella A:
Classical risk factors and emerging elements in the risk profile
for coronary artery disease. Eur Heart J. 19:A53–A61.
1998.PubMed/NCBI
|
23
|
Hirashiki A, Yamada Y, Murase Y, Suzuki Y,
Kataoka H, Morimoto Y, Tajika T, Murohara T and Yokota M:
Association of gene polymorphisms with coronary artery disease in
low- or high-risk subjects defined by conventional risk factors. J
Am Coll Cardiol. 42:1429–1437. 2003. View Article : Google Scholar : PubMed/NCBI
|
24
|
Duman BS, Turkoglu C, Akpınar B, Guden M,
Vertii A, Dak E, Cagatay P, Gunay D and Buyukdevrim AS: Lipoprotein
lipase gene polymorphism and lipid profile in coronary artery
disease. Arch Pathol Lab Med. 128:869–974. 2004.PubMed/NCBI
|
25
|
Ahn YI, Kamboh MI, Hamman RF, Cole SA and
Ferrell RE: Two DNA polymorphisms in the lipoprotein lipase gene
and their associations with factors related to cardiovascular
disease. J Lipid Res. 34:421–428. 1993.PubMed/NCBI
|
26
|
Shagisultanova EI, Mustafina OE, Tuktarova
IA and Khusnutdinova EK: HindIII polymorphism of lipoprotein lipase
gene and risk of myocardial infarction. Mol Gen Mikrobiol Virusol.
3:18–22. 2001.(In Russian).
|
27
|
Rebhi L, Kchok K, Omezzine A, Kacem S,
Rejeb J, Ben HadjMbarek I, Belkahla R, Boumaiza I, Moussa A, Ben
Rejeb N, et al: Six lipoprotein lipase gene polymorphisms, lipid
profile and coronary stenosis in a Tunisian population. Mol Biol
Rep. 39:9893–9901. 2012. View Article : Google Scholar : PubMed/NCBI
|
28
|
Peacock RE, Hamsten A, Nilsson-Ehle P and
Humphries SE: Associations between lipoprotein lipase gene
polymorphisms and plasma correlations of lipids, lipoproteins and
lipase activities in young myocardial infarction survivors and
age-matched healthy individuals from Sweden. Atherosclerosis.
97:171–185. 1992. View Article : Google Scholar
|
29
|
Thorn JA, Chamberlain JC, Alcolado JC, Oka
K, Chan L, Stocks J and Galton DJ: Lipoprotein and hepatic lipase
gene variants in coronary atherosclerosis. Atherosclerosis.
85:55–60. 1990. View Article : Google Scholar : PubMed/NCBI
|
30
|
Chamberlain JC, Thorn JA, Oka K, Galton DJ
and Stocks J: DNA polymorphisms at the lipoprotein lipase gene:
associations in normal and hypertriglyceridaemic subjects.
Atherosclerosis. 79:85–91. 1989. View Article : Google Scholar : PubMed/NCBI
|
31
|
Heinzmann C, Kirchgessner T, Kwiterovich
PO, Ladias JA, Derby C, Antonarakis SE and Lusis AJ: DNA
polymorphism haplotypes of the human lipoprotein lipase gene:
possible association with high-density lipoprotein levels. Hum
Genet. 86:578–584. 1991.PubMed/NCBI
|
32
|
Mattu RK, Needham EW, Morgan R, Rees A,
Hackshaw AK, Stocks J, Elwood PC and Galton DJ: DNA variants at the
LPL gene locus associate with angiographically defined severity of
atherosclerosis and serum lipoprotein levels in a Welsh population.
Arterioscler Thromb. 14:1090–1097. 1994. View Article : Google Scholar : PubMed/NCBI
|
33
|
Chamberlain JC, Thorn JA, Morgan R, Bishop
A, Stocks J, Rees A, Oka K and Galton DJ: Genetic variation at the
lipoprotein lipase gene associates with coronary arteriosclerosis.
Adv Exp Med Biol. 285:275–279. 1991. View Article : Google Scholar : PubMed/NCBI
|
34
|
Corella D, Guillen M, Saiz C, Portoles O,
Sabater A, Folch J and Ordovas JM: Associations of LPL and APOC3
gene polymorphisms on plasma lipids in a Mediterranean population:
interaction with tobacco smoking and the APOE locus. J Lipid Res.
43:416–427. 2002.PubMed/NCBI
|
35
|
Razzaghi H, Aston CE, Hamman RF and Kamboh
MI: Genetic screening of the lipoprotein lipase gene for mutations
associated with high triglyceride/low HDL-cholesterol levels. Hum
Genet. 107:257–267. 2000. View Article : Google Scholar : PubMed/NCBI
|
36
|
Komurcu-Bayrak E, Onat A, Poda M,
Humphries SE, Acharya J, Hergenc G, Coban N, Can G and
Erginel-Unaltuna N: The S447X variant of lipoprotein lipase gene is
associated with metabolic syndrome and lipid levels among Turks.
Clin Chim Acta. 383:110–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
37
|
Abu-Amero KK, Wyngaard CA, Al-Boudari OM,
Kambouris M and Dzimiri N: Lack of association of lipoprotein
lipase gene polymorphisms with coronary artery disease in the Saudi
Arab population. Arch Pathol Lab Med. 127:597–600. 2003.PubMed/NCBI
|
38
|
Clee SM, Bissada N, Miao F, Miao L, Marais
AD, Henderson HE, Steures P, McManus J, McManus B, LeBoeuf RC, et
al: Plasma and vessel wall lipoprotein lipase have different roles
in atherosclerosis. J Lipid Res. 41:521–531. 2000.PubMed/NCBI
|
39
|
Lee J, Tan CS, Chia KS, Tan CE, Chew SK,
Ordovas JM and Tai ES: The lipoprotein lipase S447X polymorphism
and plasma lipids: interactions with APOE polymorphisms, smoking,
and alcohol consumption. J Lipid Res. 45:1132–1139. 2004.
View Article : Google Scholar : PubMed/NCBI
|
40
|
Wung SF, Kulkarni MV, Pullinger CR, Malloy
MJ, Kane JP and Aouizerat BE: The lipoprotein lipase gene in
combined hyperlipidemia: evidence of a protective allele depletion.
Lipids Health Dis. 5:192006. View Article : Google Scholar : PubMed/NCBI
|
41
|
Chen Q, Razzaghi H, Demirci FY and Kamboh
MI: Functional significance of lipoprotein lipase HindIII
polymorphism associated with the risk of coronary artery disease.
Atherosclerosis. 200:102–108. 2008. View Article : Google Scholar : PubMed/NCBI
|
42
|
Wang XL, McCredie RM and Wilcken DE:
Common DNA polymorphisms at the lipoprotein lipase gene.
Association with severity of coronary artery disease and diabetes.
Circulation. 93:1339–1345. 1996. View Article : Google Scholar : PubMed/NCBI
|
43
|
Georges JL, Regis-Bailly A, Salah D,
Rakotovao R, Siest G, Visvikis S and Tiret L: Family study of
lipoprotein lipase gene polymorphisms and plasma triglyceride
levels. Genet Epidemiol. 13:179–192. 1996. View Article : Google Scholar : PubMed/NCBI
|
44
|
Yamana K, Yanagi H, Hirano C, Kobayashi K,
Tanaka M, Tomura S, Tsuchiya S and Hamaguchi H: Genetic
polymorphisms and mutations of lipoprotein lipase gene in Japanese
schoolchildren with hypoalphaalipoproteinemia. J Atheroscler
Thromb. 4:97–101. 1998. View Article : Google Scholar : PubMed/NCBI
|
45
|
Ye P, Pei L and Wang S: Polymorphisms of
the human lipoprotein lipase gene: possible association with lipid
levels in patients with coronary heart disease in Beijing area.
Chin Med Sci J. 11:157–161. 1996.PubMed/NCBI
|
46
|
Jemaa R, Tuzet S, Portos C, Betoulle D,
Apfelbaum M and Fumeron F: Lipoprotein lipase gene polymorphisms:
associations with hypertriglyceridemia and body mass index in obese
people. Int J Obes Relat Metab Disord. 19:270–274. 1995.PubMed/NCBI
|
47
|
Humphries SE, Nicaud V, Margalef J, Tiret
L and Talmud PJ: Lipoprotein lipase gene variation is associated
with a paternal history of premature coronary artery disease and
fasting and postprandial plasma triglycerides: the European
Atherosclerosis Research Study (EARS). Arterioscler Thromb Vasc
Biol. 18:526–534. 1998. View Article : Google Scholar
|
48
|
Henderson HE, Kastelein JJ, Zwinderman AH,
Gagne E, Jukema JW, Reymer PW, Groenemeyer BE, Lie KI, Bruschke AV,
Hayden MR and Jansen H: Lipoprotein lipase activity is decreased in
a large cohort of patients with coronary artery disease and is
associated with changes in lipids and lipoproteins. J Lipid Res.
40:735–743. 1999.PubMed/NCBI
|
49
|
Gagne SE, Larson MG, Pimstone SN, Schaefer
EJ, Kastelein JJ, Wilson PW, Ordovas JM and Hayden MR: A common
truncation variant of lipoprotein lipase (Ser447X) confers
protection against coronary heart disease: the Framingham Offspring
Study. Clin Genet. 55:450–454. 1999. View Article : Google Scholar
|
50
|
Groenemeijer BE, Hallman MD, Reymer PW,
Gagne E, Kuivenhoven JA, Bruin T, Jansen H, Lie KI, Bruschke AV,
Boerwinkle E, et al: Genetic variant showing a positive interaction
with beta-blocking agents with a beneficial influence on
lipoprotein lipase activity, HDL cholesterol, and triglyceride
levels in coronary artery disease patients. The Ser447-stop
substitution in the lipoprotein lipase gene. REGRESS Study Group.
Circulation. 95:2628–2635. 1997.
|
51
|
Alper AT, Hasdemir H, Sahin S, Onturk E,
Akyol A, Nurkalem Z, Cakmak N, Erdinler I and Gurkan K: The
relationship between nonalcoholic fatty liver disease and the
severity of coronary artery disease in patients with metabolic
syndrome. Turk Kardiyol Dern Ars. 36:376–381. 2008.
|
52
|
Goodarzi MO, Guo X, Taylor KD, Quinones
MJ, Samayoa C, Yang H, Saad MF, Palotie A, Krauss RM, Hsueh WA and
Rotter JI: Determination and use of haplotypes: ethnic comparison
and association of the lipoprotein lipase gene and coronary artery
disease in Mexican-Americans. Genet Med. 5:322–327. 2003.
View Article : Google Scholar : PubMed/NCBI
|